Blue Venture Fund led a round that included corporate venturing units GV and Optum Ventures, taking the medical imaging system developer's total funding to almost $60m.
UK-based cardiovascular imaging technology provider Ultromics secured $33m yesterday in a series B round led by Blue Venture Fund, a vehicle backed by 35 Blue Cross and Blue Shield Association health insurers.
The round also featured internet and technology group Alphabet’s GV unit as well as Optum Ventures, the corporate venturing arm of health services provider Optum, and Oxford Sciences Innovation (OSI), a venture capital partner of University of Oxford.
Founded in 2017 and spun out of University of Oxford,…
Fernando Moncada Rivera
Fernando Moncada Rivera is a reporter at Global Corporate Venturing and also host of the CVC Unplugged podcast.
